Beyond Type 2 Advocacy


We Believe

Everyone impacted by diabetes—type 1, type 2, and beyond—has a right to the best care possible for their unique situation. This means having access to the technology, medications, support and clinical care teams that help each individual manage their chronic condition. We work to increase access and remove barriers, giving our community the tools needed to succeed.

High quality, modern insulin must be available to people with diabetes regardless of employment or insurance status, across all demographics, without barriers and at an affordable and predictable price point.

Our advocacy work focuses on equity: making sure people with diabetes have access to care by tackling issues like systemic racism, financial privilege and discrimination in all its forms.

Federal Actions

If Congress doesn’t hear about what matters to our community, they won’t take action. Sending messages to your elected representatives is one of many ways to raise your voice on important issues impacting people with diabetes. The latest actions available are listed below, but keep checking back, as new bills are introduced often.

What you can do right now: fill out your name and street address and click next. Our grassroots platform will find your elected representatives and walk you through sending a message to let them know your thoughts!

State Actions

States have power over our health through budgets and bills, so it’s just as important to let our state representatives know how their decisions can impact our daily diabetes management.

State insulin price capping bills have been one way to provide financial relief to some members of our community. However, these bills only assist those who have select state-regulated commercial insurance. To learn more about the limitations of insulin capping bills, click here.

We are actively monitoring these state insulin price capping bills (listed below), as we believe that even helping a few community members with out-of-pocket costs is one step closer to ensuring all people with diabetes in the United Sates have affordable access to insulin. If you’re interested in learning more about a particular bill and where it stands in the state’s legislature process, click on the name of the bill.


Self-Advocacy Cards For Your Next Doctor Appointment

Need help advocating for yourself during doctor appointments? Here are some cards you can use to help address your concerns with a doctor.MORE

Questions to Ask Before Starting New Medications

Starting a new medication can be a tough decision but asking your provider the right questions can help you feel empowered in your decision.MORE
drug rebates

Drug Rebates, Insulin and Affording Life with Diabetes in the United States

The issues surrounding drug rebates in the U.S. highlight the need for reform, especially when it comes to insulin and living with diabetes.MORE

How Insulin Pricing Works in the U.S.

The American healthcare system has created a complex web of players who exchange money for pharmaceutical products in ways that are not entirely clear.MORE

A new program of Beyond Type 1, connecting people with diabetes who take insulin to assistance programs and low-cost solutions that match their unique situation.MORE

The Power of the Diabetes Vote

Over 34 million Americans and their families are impacted by diabetes. Those votes add up, and every individual vote is important!MORE

How to Vote – A Guide for the Diabetes Community

A full breakdown of how to vote in any election, and why your vote matters to the diabetes community! Use this guide to get your vote in!MORE


Beyond Type 1 United Nations

Beyond Type 1 Calls on World Leaders at United Nations, Addressing Universal Health Coverage

Beyond Type 1 and other panelists at the United Nations Hearings discussed enabling people living with noncommunicable diseases’ rights to health.MORE
insulin now act

The Affordable Insulin Now Act: A Step Toward Federal Legislation

The Affordable Insulin Now Act, if passed in its current form, could help bring down the cost of insulin for millions of insured people with diabetes.MORE

Inside the Senate Report on Rising Insulin Prices

A January 2021 Senate Finance Committee report dug into the rapidly increasing cost of insulin. Here, we summarize and explain their findings.MORE

Get the Facts on Insulin Pricing + The Presidential Transition

A flurry of misinformation is stoking fears that the Biden Admin paused or reversed a previous Trump Admin policy that lowered the price of insulin. MORE